POVIDONE-IODINE BETADINE

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

PATIENT INFORMATION LEAFLET. Naseptin Nasal Cream chlorhexidine dihydrochloride and neomycin sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER

PHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine.

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

FASTUM 2.5% gel PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT FASTUM GEL IS AND WHAT IT IS USED FOR

AUGMENTIN is also used to prevent infection from major surgery.

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Bicillin L-A Benzathine benzylpenicillin tetrahydrate

PATIENT INFORMATION LEAFLET. Nasoxyl nasal spray solution 1 mg/ml

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.

How Entecavir GH Works

Package leaflet: Information for the patient. Megalac Almasilate 1 g/10 ml suspension. Active substance: almasilate

PATIENT INFORMATION LEAFLET CARZIN XL

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

PATIENT INFORMATION LEAFLET PEPLOC RANGE

DIXARIT 25 mcg Tablets Clonidine Hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

Dulcolax Tablets and Dulcolax Suppositories Bisacodyl

Package leaflet: Information for the patient UNITED KINGDOM Feldene 5mg/g Gel piroxicam

SPASMEX FORTE 5mg tablets

Ceclor CD cefaclor monohydrate sustained release tablets

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

SUCRALFATE ISELPIN 1 g Tablet

PATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid)

1.3.1 PACKAGE LEAFLET: INFORMATION FOR THE USER

NEXIUM INTRAVENOUS esomeprazole sodium

BISOLVON Chesty Forte.

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

PATIENT INFORMATION LEAFLET

FLUIMUKAN PLUS 600 mg effervescent tablets

Package leaflet: Information for the patient. Xemacort 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

PATIENT INFORMATION LEAFLET DYNARB RANGE

PATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate

Patient Information Leaflet

REDERGIN 1.5 mg tablets; 4.5 mg tablets; 1 mg/ml oral solution

PHARMACY ACTION COLD & FLU DAY & NIGHT paracetamol, pseudoephedrine hydrochloride, chlorphenamine maleate

PATIENT INFORMATION LEAFLET AMLOC RANGE

Glucophage XR is contra-indicated during breast-feeding.

Patient Information MICARDIS HCT (my-car-dis HCT) (telmisartan and hydrochlorothiazide) Tablets

DESCRIPTION Locacorten-Vioform ear drops are a practically odourless clear, yellowish to brownish-yellow solution. Excipients: Macrogol 300

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

APOHEALTH Diarrhoea Relief PLUS

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory. Neomycin Sulphate, Polymyxin B Sulfate and Bacitracin Zinc Powder

Sensipar Cinacalcet hydrochloride

Package leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

Hydrocortisyl Skin Cream 1% Hydrocortisone

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

METHYLDOPA 250 mg Film-coated Tablets

MEDICATION GUIDE SUTENT

Package leaflet: Information for the user. Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium)

FAVISTAN 20 mg, tablets

1. What Solpadol is and what it is used for

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have.

PRESCRIBING INFORMATION

Flavamed Forte 30 mg/5 ml, oral solution

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Before you are given Privigen

PACKAGE LEAFLET: INFORMATION FOR THE USER. Xylonase 0.1% w/v Nasal Spray, Solution Xylometazoline hydrochloride

2. What you need to know before you take DDAVP/Desmopressin Tablets

PATIENT INFORMATION LEAFLET TEXAMER

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Duro-Tuss Dry Cough Liquid plus Nasal Decongestant Pholcodine (fol-co-dean); Pseudoephedrine hydrochloride (sue-doe-eff-eh-drine hydro-klor-ide)

PART III: PATIENT MEDICATION INFORMATION. CLINDAMYCINE-150 Pr. CLINDAMYCINE-300 (Clindamycin Hydrochloride Capsules USP) Clindamycin 150 mg and 300 mg

PATIENT INFORMATION LEAFLET CARVETREND RANGE

NEOFEN 60 mg suppository

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate

Thyroid Gland. Patient Information

Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride

PRODUCT MONOGRAPH. Pr KYTRIL. granisetron hydrochloride tablets. 1 mg granisetron as hydrochloride. Manufacture Standard

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Kaliumjodide G.L. 65 mg tabletten Potassium iodide

Irbenida H 150mg/12,5mg film-coated tablets

Dulcolax 5 mg, film-coated tablets

Consumer Medicine Information PIMAFUCORT

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

Lovastatin tablets 20 and 40 mg PACKAGE LEAFLET

Mycamine Micafungin (as sodium)

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracetamol 500 mg Effervescent Tablets Paracetamol

Package leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. ANESDERM 25 mg/g + 25 mg/g Cream Lidocaine, Prilocaine

Transcription:

POVIDONE-IODINE BETADINE NAME OF PRODUCT BETADINE 10% OINTMENT Read this leaflet carefully before you start using BETADINE ointment. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. DESCRIPTION OF PRODUCT POVIDONE-IODINE (BETADINE ) ointment is a reddish brown, smooth, homogenous ointment. It is available in 5 & 15 g aluminum tube. 1. WHAT IS BETADINE OINTMENT? POVIDONE-IODINE (BETADINE ) ointment is a topical agent active against organisms commonly encountered in skin and wound infections. It contains 10% povidone-iodine equivalent to 1% available iodine. The active ingredient povidone-iodine substantially retains the broad spectrum germicidal activity of iodine against the commonly encountered organisms in skin and wound infections, without the undesirable features or disadvantages of iodine. POVIDONE-IODINE (BETADINE ) ointment is decisively microbicidal against all 4 major classes of pathogens: bacteria (both Gram-positive and Gram-negative, as well as antibiotic-resistant strains) fungi, viruses and protozoa. The foremost documented broad spectrum topical microbicidal power of POVIDONE-IODINE (BETADINE ) ointment is active even in the presence of blood, pus and serum and the germicidal activity is more prolonged than that of iodine tincture. POVIDONE-IODINE (BETADINE ) ointment is in a water-soluble base and is not greasy or sticky. It permits bandaging of treated area, is virtually non-irritating to skin and mucosa and does not block air from reaching site of application. It easily washes off from skin and natural fabrics. POVIDONE-IODINE (BETADINE ) ointment does not interfere with granulation or skin grafting in burns. 2. STRENGTH OF BETADINE OINTMENT Each g contains 100 mg POVIDONE-IODINE (BETADINE ) equivalent to 10 mg available iodine 3. WHAT IS BETADINE OINTMENT USED FOR? POVIDONE-IODINE (BETADINE ) ointment is an ideal topical agent for the treatment of common skin infections; prevention of infection in minor burns, lacerations, cuts and abrasions; and for infection control during insertion and care of urinary catheters, circumcision, suture removal and dressing changes.

POVIDONE-IODINE (BETADINE ) ointment may be used for degerming care of stasis ulcers, decubitus ulcers and the umbilical area. It can be used also for degerming during use of intravenous devices in blood transfusions, hyperalimentation, cutdowns, CVP catheterization and in other procedures where degerming is needed. 4. HOW MUCH AND HOW OFTEN SHOULD YOU USE BETADINE OINTMENT? Use POVIDONE-IODINE (BETADINE ) Ointment as prescribed by your doctor. Clean and dry the affected skin. Apply POVIDONE-IODINE (BETADINE ) ointment liberally and cover with a dressing or bandage. POVIDONE-IODINE (BETADINE ) ointment may be used as often as required. If you have any further questions on the use of POVIDONE-IODINE (BETADINE ) ointment, ask your doctor or pharmacist. 5. WHEN SHOULD YOU NOT USE BETADINE OINTMENT? POVIDONE-IODINE (BETADINE ) ointment should not be used: If you are allergic to iodine or povidone If you have an overactive thyroid gland (hyperthyroidism) or any thyroid diseases If you are on lithium therapy Before and after a specific medical treatment involving the use of radioactive iodine If you feel you have experienced an allergic reaction, stop using POVIDONE-IODINE (BETADINE ) ointment and inform your doctor or pharmacist immediately. 6. SIDE EFFECTS All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical attention if you get some of the side effects. The side effects listed below may not include all of the side effects reported. For more information about any other possible risks associated with POVIDONE-IODINE (BETADINE ) ointment, please consult your doctor or pharmacist. Please note that the side effects related to the use of POVIDONE-IODINE (BETADINE ) ointment occur rarely. Rarely, hypersensitive/allergic skin reaction may occur, which can appear in the form of: itchiness redness small blisters Very rarely, acute generalized allergic reactions have been reported with drop in blood pressure difficulty in breathing swelling of the skin and mucosa

If you notice any side effects, please consult your doctor or pharmacist. The long term use of the product, not in accordance with the usage instructions mentioned under section 4, may lead to possible absorption of iodine into the body. This may lead to overactive thyroid gland function if you have a history of thyroid problems, rapid heartbeat (tachycardia) and restlessness imbalance of electrolytes abnormal blood concentration (osmolarity) abnormal kidney function (renal impairment) 7. WHAT OTHER MEDICINE OR FOOD SHOULD BE AVOIDED WHILE USING BETADINE OINTMENT? Do not apply other medications to the same affected areas you treat with POVIDONE- IODINE (BETADINE ) ointment, unless your doctor has told you so. It is not likely that other drugs you take orally or inject will have an effect on externally applied POVIDONE-IODINE (BETADINE ) ointment. The concomitant use of other externally applied wound healing medicines /preparations may alter the effect of POVIDONE-IODINE (BETADINE ) ointment or both. Products containing enzymatic component, alkali, mercury, silver, hydrogen peroxide, tannic acid and taurolidine may interact with povidone-iodine and should not be used concomitantly. Povidone-iodine products when used concomitantly or immediately after application of octenidine containing antiseptics in the same or adjacent sites may lead to transient dark discolorations in the areas involved. Due to the oxidative effect of povidone-iodine preparations various diagnostic agents can show false-positive lab results (e.g., tests with toluidine or gum guaiac for the determination of hemoglobin or glucose in the stool or the urine). Absorption of iodine from povidone-iodine may interfere with thyroid function tests. Do not start a new treatment medication without telling your doctor. For more information about any other possible risks associated with POVIDONE-IODINE (BETADINE ) ointment, please consult your doctor or pharmacist. 8. WHAT SHOULD YOU DO IF YOU MISS A DOSE? Follow the usage instructions mentioned in section 4. If you miss a treatment use it as soon as you remember. For more information please consult your doctor or pharmacist. 9. HOW SHOULD YOU KEEP BETADINE OINTMENT? Do not use POVIDONE-IODINE (BETADINE ) ointment after the expiry date indicated on the tube and carton. Store at temperatures not exceeding 30 C. 10. SIGNS & SYMPTOMS OF OVERDOSE In the unlikely event you experience any of the following symptoms: stomach pain, unable to pass urine, loss of appetite, weakness, nausea and vomiting, coughing up

blood, excessive sweating, difficulty in breathing, metabolic acidosis, anxiety and pale skin, immediately consult your doctor. Treatment is symptomatic and supportive. 11. WHAT TO DO WHEN YOU HAVE USED MORE THAN THE RECOMMENDED DOSAGE? Please consult your doctor or pharmacist. 12. CARE THAT SHOULD BE TAKEN WHEN USING BETADINE OINTMENT In pre-operative preparation, avoid pooling beneath the patient. Prolonged exposure to wet solution may cause irritation or rarely, severe skin reactions. Chemical burns of skin due to pooling may occur. In instances of skin irritation, contact dermatitis or hypersensitivity, discontinue use. Do not heat POVIDONE-IODINE (BETADINE ) ointment prior to use. Avoid getting POVIDONE-IODINE (BETADINE ) ointment in your eyes. Avoid solutions containing a detergent if treating open wounds with povidone-iodine. POVIDONE-IODINE (BETADINE ) ointment is intended FOR EXTERNAL USE ONLY. Not for use on extensive body areas and should not be used over a long period of time unless strictly indicated. Patients with goiter, thyroid nodules or other non-acute thyroid diseases are at risk of developing thyroid hyperfunction (hyperthyroidism) from the administration of large amounts of iodine. In this patient population, povidone-iodine should not be applied for an extended period of time and to large areas of the skin unless strictly indicated. Even after the end of the treatment one should look for the early symptoms of possible hyperthyroidism and if necessary the thyroid function should be monitored. It should not be used prior to or after radioiodine scintigraphy or radioiodine treatment of thyroid carcinoma. Newborns and small infants are at increased risk of developing hypothyroidism from the administration of large amounts of iodine. Because of the permeable nature of the skin and their increased sensitivity to iodine, the use of povidone-iodine should be kept to the absolute minimum in newborns and small infants. A check of their thyroid function (e.g. T 4 levels and TSH levels) may be necessary. Avoid use in patients with renal impairment. If symptoms persist, consult your doctor. Pregnancy and Lactation During pregnancy and lactation, POVIDONE-IODINE (BETADINE ) ointment should only be used if strictly prescribed by the doctor and its use should be kept to the absolute minimum. Seek medical advice from your doctor or pharmacist. 13. WHEN SHOULD YOU CONSULT YOUR DOCTOR? In case of allergic symptoms, stop treatment and consult your doctor.

Call your doctor if your symptoms do not improve or if they get worse. Also call your doctor if your symptoms had cleared up but reappeared again. Manufactured for: By: Mundipharma Distribution GmbH Interphil Laboratories, Inc. (Philippine Branch) Canlubang Industrial Estate, 29/F Robinsons Equitable Tower, Bo. Pittland, Cabuyao, Laguna #4 ADB Ave. cor. Poveda St., Ortigas Center, Pasig City, Philippines 1605 Under license by: Mundipharma B.V. / The Netherlands : BETADINE is a Registered Trademark. This leaflet was last revised on December 10, 2015 (CCDS v.4 16 November 2015). PH-BET-0566-V3-1215